Q4 2024 Management View CEO Marc Casper highlighted a strong finish to 2024, with revenue growing 5% year-over-year to $11.4 billion and adjusted EPS up 8% to $6.10. He emphasized market share gains ...
NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platformFindings in lung cancer show that CTCs can provide additional biomarkers not found in ctDNA from single ...
Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...
Increase in the prevalence of infectious diseases, increase in awareness of food safety issues, and rise in technological advancements drive the growth.
CLASS data FOR NOVEL APPROACH TO CANCER treatmentParsortix system used to identify patients with highly metastatic CTC clusters for targeted treatmentNew treatment strategy provides 'uncharted ...